Chenglong Han

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Chenglong Han, Don Robinson, Monica Hackett et al. · PubMed · 2006 · 720 citations

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

Josef S Smolen, Chenglong Han, M Bala et al. · Arthritis & Rheumatism · 2005 · 455 citations

Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

Josef S Smolen, Désirée van der Heijde, E. William St. Clair et al. · Arthritis & Rheumatism · 2006 · 433 citations · Full text

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Richard G. Langley, Steven R. Feldman, Chenglong Han et al. · Journal of the American Academy of Dermatology · 2010 · 213 citations

Psychoneuroimmunology, Psychiatry, Systemic Treatment +8

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

William J. Sandborn, Geert D’Haens, Walter Reinisch et al. · Gastroenterology · 2022 · 188 citations · Full text